Literature DB >> 8923468

Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.

W Yi1, S O Kim, J Jiang, S H Park, A S Kraft, D J Waxman, S J Frank.   

Abstract

GH-induced activation of JAK2, a GH receptor (GHR)-associated tyrosine kinase, leads to tyrosine phosphorylation and activation of STATs (signal transducers and activators of transcription) 1, 3, and 5. The present study investigates the importance of the GHR cytoplasmic domain in the activation of STAT3 and STAT5b. As the perimembranous Box1 region of the GHR cytoplasmic domain is necessary for activation of wild-type (WT) JAK2 by GH, we examined this question using GHR/JAK2 chimeras that have an activatable JAK2 kinase domain replacing the GHR cytoplasmic domain. STAT5b and STAT3, when each was coexpressed in COS-7 cells with WT GHR and WT JAK2, were both strongly tyrosine phosphorylated in response to GH. Coexpression of STAT3 with GHR/ JAK2 chimeras resulted in a strong GH-independent tyrosine phosphorylation of STAT3 that was 40% as active as that seen with WT GHR plus WT JAK2, whereas STAT5b was more minimally phosphorylated (13% of WT GHR plus WT JAK2) when coexpressed with chimeras devoid of the GHR cytoplasmic domain. Transient coexpression of each STAT together with WT JAK2 and GHR COOH-terminal truncation mutants indicated that a GH-induced STAT3-DNA binding complex, but not a STAT5b-DNA binding complex, was detectable when a GHR devoid of 85% of the cytoplasmic domain COOH-terminus (but eliciting significant JAK2 tyrosine phosphorylation) was expressed. In vitro binding experiments using GST/GHR cytoplasmic domain fusions demonstrated that both STATs could interact at a low basal level with GHR regions distal to residue 317. Phosphorylation of tyrosine residues in those distal regions greatly enhanced the receptor's interaction with STAT5b, but not STAT3. We conclude that GH induces activation of STAT3 and STAT5b by two different pathways: one primarily dependent on activation of JAK2 (STAT3) and another that is additionally reliant on the presence of an intact and tyrosine-phosphorylated GHR cytoplasmic domain (STAT5b).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8923468     DOI: 10.1210/mend.10.11.8923468

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  17 in total

1.  Identification of SH2B2beta as an inhibitor for SH2B1- and SH2B2alpha-promoted Janus kinase-2 activation and insulin signaling.

Authors:  Minghua Li; Zhiqin Li; David L Morris; Liangyou Rui
Journal:  Endocrinology       Date:  2007-01-04       Impact factor: 4.736

2.  Hepatic growth hormone resistance after acute injury.

Authors:  Ryan M Corrick; Li Li; Stuart J Frank; Joseph L Messina
Journal:  Endocrinology       Date:  2013-02-15       Impact factor: 4.736

3.  Growth hormone-induced JAK2 signaling and GH receptor down-regulation: role of GH receptor intracellular domain tyrosine residues.

Authors:  Luqin Deng; Jing Jiang; Stuart J Frank
Journal:  Endocrinology       Date:  2012-03-13       Impact factor: 4.736

4.  Identification of SH2-bbeta as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2.

Authors:  L Rui; C Carter-Su
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

Review 5.  Modulation of growth hormone receptor abundance and function: roles for the ubiquitin-proteasome system.

Authors:  Stuart J Frank; Serge Y Fuchs
Journal:  Biochim Biophys Acta       Date:  2008-06-09

6.  Increased renal Akt/mTOR and MAPK signaling in type I diabetes in the absence of IGF type 1 receptor activation.

Authors:  Daniel Landau; Renanah Eshet; Ariel Troib; Yotam Gurman; Yu Chen; Ralph Rabkin; Yael Segev
Journal:  Endocrine       Date:  2009-04-23       Impact factor: 3.633

Review 7.  Mechanistic aspects of crosstalk between GH and PRL and ErbB receptor family signaling.

Authors:  Stuart J Frank
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-31       Impact factor: 2.673

8.  Human GH receptor-IGF-1 receptor interaction: implications for GH signaling.

Authors:  Yujun Gan; Ashiya Buckels; Ying Liu; Yue Zhang; Andrew J Paterson; Jing Jiang; Kurt R Zinn; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2014-09-11

9.  Differential effects of STAT proteins on growth hormone-mediated IGF-I gene expression.

Authors:  Ben Varco-Merth; Peter Rotwein
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-09-09       Impact factor: 4.310

10.  Interruption of growth hormone signaling via SHC and ERK in 3T3-F442A preadipocytes upon knockdown of insulin receptor substrate-1.

Authors:  Xiangdong Wang; Ning Yang; Luqin Deng; Xin Li; Jing Jiang; Yujun Gan; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2009-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.